Joint Statement on Impact of Shutdown on Therapy Review
The following statement is posted in response to published reports concerning the impact of the government shutdown on review by the Food and Drug Administration (FDA) of therapies for food allergy:
We are hopeful that the government shutdown will end as soon as possible so that the FDA can get back to work reviewing potential food allergy treatments. It is imperative that any potential treatments are processed through the system quickly, as patients' lives are at stake.
Delays of any kind prolong the long wait for a potentially life-saving therapy for peanut allergy. We hope that our leaders can find a way to reach an agreement and let the FDA continue their work.
--Allergy & Asthma Network, Asthma and Allergy Foundation of America, Center for Science in the Public Interest and Food Allergy Research & Education
Food Allergy Research & Education (FARE) is the world’s leading food allergy advocacy organization and the largest private funder of food allergy research. Our mission is to improve the quality of life and the health of individuals with food allergies, and to provide them hope through the promise of new treatments. FARE is transforming the future of food allergy through innovative initiatives that will lead to increased awareness, new and improved treatments and prevention strategies, effective policies and legislation and novel approaches to managing the disease. For more information, please visit www.foodallergy.org. To join FARE’s transformative five-year fundraising and awareness campaign, Contains: Courage™, supporting families living with food allergies and educating ALL communities about the disease, visit www.foodallergy.org/containscourage.